- Dillard’s Inc (NYSE:DDS) disclosed a newly authorized share repurchase program and a cash dividend.
- The company’s board of directors authorized a share repurchase program of up to $500 million. DDS has completed its previous share repurchase program.
- The company also declared a cash dividend of $0.20 per share, payable on July 31, 2023, to shareholders of record as of June 30, 2023.
- On May 11, the company reported Q1 2023 revenues of $1.58 billion, exceeding the consensus of $1.54 billion, and EPS of $11.85 beat the analyst expectations of $10.77.
- In Q1, the company repurchased shares worth $113.8 million and had $61.6 million worth of shares remaining under the authorization as of April 29, 2023.
- Operating cash flow stood at $280.9 million in the quarter. Cash and cash equivalents came in at $848.3 as of April 29, 2023.
- Price Action: DDS shares are trading higher by 6.12% at $295.01 on the last check Monday.
- Photo via Wikimedia Commons
Kronos Bio Presents Preliminary Data From Phase 1 Dose Escalation Portion Of Phase 1/2 KB-0742 Study At AACR-NCI-EORTC
Demonstrated on-mechanism, single agent anti-tumor activity in heavily pre-treated patients with transcriptionally addicted solid tumors Showed manageable safety profile, with no grade 3/4 neutropenia, dose
